In a surprising development, the FDA has issued a stark warning concerning antiseizure medications levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan). These drugs, ...

Here are four things to know. 1. Levetiracetam is intended to treat partial onset seizures related to epilepsy. 2. The tablets are a generic equivalent to UCB’s brand name drug Keppra XR. 3. Sales of ...

Patients prescribed levetiracetam or clobazam should be informed about the risk of DRESS. The Food and Drug Administration (FDA) has issued a safety alert regarding the risk of DRESS (drug reaction ...

Description: Clinical trial evaluating the safety and efficacy of levetiracetam in epileptic dogs whose seizures are poorly controlled with standard anticonvulsant medications Eligibility: Dogs must ...

Antiseizure medications made of levetiracetam and clobazam might cause a rash that can quickly injure organs and hospitalize patients, the FDA said Nov. 28. The reaction, called DRESS (drug reaction ...

MUMBAI, May 23 (Reuters) - Drug maker Alembic Ltd. said on Wednesday it had signed a deal to out-license its novel drug delivery platform to Belgium's UCB for the latter's anti-epileptic drug Keppra ...